As a continuation of the recent drug pricing developments tied the Trump Administration’s American ..
At the end of July, CMS approved two Section 1332 State Innovation Waivers submitted by Wisconsin and Maine ..
On Wednesday, August 8, CMS filed a proposed rule clearing the way for the federal government to continue ..
States are increasingly looking for ways to improve stability in their individual insurance marketplaces. ..
In May, the Trump Administration announced its Blueprint to Lower Drug Prices and HHS Secretary Azar ..
It seems like every week, there are multiple new developments in the 340B program. While it has just ..
The government is focusing on opioids. Whether it be program policies, enforcement, or legislation, ..
On June 19, the Health Policy Consensus Group, which is a group led by former Sen. Rick Santorum (R-PA) ..
A lot has happened since we last addressed new biosimilar developments in January 2018. In the intervening ..
On Thursday June 14, 2018, the US Court of Appeals for the Federal Circuit ruled against two health plans ..
Many provisions of the Affordable Care Act (“ACA”) have been the subject of litigation over the last ..
This week the Senate Finance Committee will mark up its opioid package. Additionally, the HELP Committee ..
States may be starting to take aim at prescription automatic refill programs. Automatic refill programs ..
On Friday, after weeks of delay, the President finally delivered his Drug Pricing Speech and released ..
On Wednesday May 9th, I was floored when the Administration released the Spring 2018 Unified Agenda of Regulatory ..
Mintz Levin has updated the Mintz Matrix, a comprehensive summary of the data breach notification laws ..
On Monday, CMS published a number of policies changing the dynamics of the individual market, including ..
The all-too-common story of a healthcare company declaring bankruptcy in the face of aggressive Medicare ..
As we highlighted earlier this month, CMS released both the Contract Year 2019 Final Rules for Medicare ..
In a recent Antitrust Alert, our colleagues Dionne Lomax, Bruce Sokler, Robert Kidwell, and Shawn Skolky ..